Yüklüyor......
Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
The methylation of O(6)-methylguanine DNA methyltransferase (MGMT) gene promoter is a key biological marker in clinical neuro-oncology. Nevertheless, there is no consensus concerning the best technique for its assessment. In a recent study comparing five methods to analyze MGMT status, we found that...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3905192/ https://ncbi.nlm.nih.gov/pubmed/24420923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-013-1332-y |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|